Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics Duration Post PCNL for Infection Stones
NCT02375295Phase 4Unknown
- Sponsor
- University of British Columbia
- Start
- Mar 2015
- Primary completion
- Dec 2023
- Modality
- Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 4 trial of ciprofloxacin, trimethoprim + sulfamethoxazole, nitrofurantoin in nephrolithiasis, sponsored by University of British Columbia. Status: unknown.
02
Drugs
ciprofloxacintrimethoprim + sulfamethoxazolenitrofurantoin
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT02375295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02375295.